• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24733 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     NIHR Horizon Scanning Centre (NIHR HSC) Remestemcel-L (Prochymal) for steroid refractory acute graft versus host disease – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Remestemcel-L for graft vs host disease in paediatric patients – second line
2011     HAYES, Inc. Remicade (Infliximab; Janssen Biotech Inc., a Johnson&Johnson Company) for treatment of neurosarcoidosis
2011     HAYES, Inc. Remicade (Infliximab; Janssen Biotech Inc., a Johnson&Johnson Company) for treatment of pulmonary sarcoidosis
2013     HAYES, Inc. Remicade (infliximab; Janssen Biotech Inc.) for first-line treatment of pediatric crohn's disease
2006     NIHR Horizon Scanning Centre (NIHR HSC) Remiplistim (AMG 531) for idiopathic thrombocytopenic purpura: horizon scanning technology note
2025     NIHR Health and Social Care Delivery Program Remote and digital services in UK general practice 2021–2023: the Remote by Default 2 longitudinal qualitative study synopsis
2007     Agency for Healthcare Research and Quality (AHRQ) Remote cardiac monitoring
2012     HAYES, Inc. Remote cognitive-behavioral therapy for bulimia nervosa
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Remote ischemic conditioning: a review of the clinical effectiveness
2008     Adelaide Health Technology Assessment (AHTA) Remote monitoring for implantable cardiac devices
2023     NIHR Health Services and Delivery Research programme Remote monitoring for long-term physical health conditions: an evidence and gap map
2010     Belgian Health Care Knowledge Centre (KCE) Remote monitoring for patients with implanted defibrillators. Technology evaluation and broader regulatory framework
2020     Health Technology Wales (HTW) Remote monitoring of blood glucose in women with gestational diabetes
2003     NIHR Horizon Scanning Centre (NIHR HSC) Remote monitoring of implantable cardiac devices - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Remote monitoring of implantable cardiac devices for cardiac arrhythmia - horizon scanning review
2018     Health Quality Ontario (HQO) Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment
2021     Belgian Health Care Knowledge Centre (KCE) Remote monitoring of patients with cardiovascular implantable electronic devices: a health technology assessment (update of the KCE Report 136)
2008     HAYES, Inc. Remote monitoring of patients with congestive heart failure
2014     Medical Services Advisory Committee (MSAC) Remote monitoring of patients with implanted cardiac devices
2014     Medical Services Advisory Committee (MSAC) Remote monitoring of patients with implanted cardiac devices (resubmission)
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Remote monitoring programs for cardiac conditions
2006     Adelaide Health Technology Assessment (AHTA) Remote monitoring systems for implantable cardiac devices (cardioverter defibrillators andpacemakers)
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2010     Adelaide Health Technology Assessment (AHTA) Remote-controlled catheter navigation systems
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Removable rigid dressings for leg amputation: a review of the clinical effectiveness, cost effectiveness and guidelines
2010     The Regional Health Technology Assessment Centre (HTA-centrum) Removal of impacted wisdom teeth
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Removal of intravenous lines following outpatient day procedures: guidelines
2019     Swiss Federal Office of Public Health (FOPH) Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Removal of physical restraints in long term care settings: clinical safety and harm
2023     National Institute for Health and Care Excellence (NICE) Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatment. NICE interventional procedures guidance 772
2022     National Institute for Health and Care Excellence (NICE) Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause. NICE interventional procedures guidance 738
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) Renal artery ablation in patients with treatment-resistant hypertension: a systematic review
2016     Agency for Healthcare Research and Quality (AHRQ) Renal artery stenosis management strategies: an updated comparative effectiveness review
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Renal denervation
2013     New Zealand National Health Committee (NHC) Renal denervation – technology note
2024     Austrian Institute for Health Technology Assessment (AIHTA) Renal denervation (RDN) in patients with treatment resistant hypertension. 2nd Update
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Renal denervation for resistant hypertension
2024     Penn Medicine Center for Evidence-based Practice (CEP) Renal denervation for treatment of resistant hypertension
2016     Agency for Healthcare Research and Quality (AHRQ) Renal denervation in the Medicare Population
2023     Health Technology Wales (HTW) Renal denervation to treat people with resistant hypertension
2006     HAYES, Inc. Renal stenting for treatment of renal stenosis in patients with hypertension
2010     Adelaide Health Technology Assessment (AHTA) Renal sympathetic denervation for the treatment of resistant hypertension
2013     The Regional Health Technology Assessment Centre (HTA-centrum) Renal sympathetic denervation in patients with therapy resistant hypertension
1997     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Renal-pancreatic transplantation - primary research
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for advanced or metastatic pancreatic cancer – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for relapsed or refractory multiple myeloma
2015     NIHR Health Services and Delivery Research programme Reorganising specialist cancer surgery for the 21st century: a mixed methods evaluation (RESPECT-21)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reparixin for prevention of delayed graft function in pancreatic islet transplantation for type 1 diabetes mellitus
2023     Health Information and Quality Authority (HIQA) Repatriation of paediatric haematopoietic stem cell transplant services to Ireland: a Health Technology Assessment
2001     Wessex Institute for Health Research and Development (WIHRD) Repeat inpatient rehabilitation for people with relapsed alcohol addiction
2021     National Institute for Health and Care Excellence (NICE) Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma. NICE interventional procedures guidance 692
2000     Health Council of the Netherlands Gezondheidsraad (GR) Repetitive strain injury
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Repetitive transcranial magnetic stimulation
2007     Medical Services Advisory Committee (MSAC) Repetitive transcranial magnetic stimulation (rTMS)
2020     Malaysian Health Technology Assessment (MaHTAS) Repetitive transcranial magnetic stimulation (rTMS) for patients with stroke
2014     Medical Services Advisory Committee (MSAC) Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression
2021     Agency for Care Effectiveness (ACE) Repetitive transcranial magnetic stimulation for adults with treatment resistant major depressive disorder
2015     National Institute for Health and Care Excellence (NICE) Repetitive transcranial magnetic stimulation for depression. NICE interventional procedures guidance 542
2021     Ontario Health Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Repetitive transcranial magnetic stimulation for specific patient populations: clinical and cost-effectiveness and safety
2004     Medical Advisory Secretariat (MAS) Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis
2014     HTA Unit, University of Calgary Repetitive transcranial magnetic stimulation for treatment resistant depression
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment- resistant depression: a systematic review and meta-analysis of randomized controlled trials
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: an economic analysis
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: OHTAC recommendation
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Repetitive transcranial magnetic stimulation for treatment-resistant major depression
2017     European Network for Health Technology Assessment (EUnetHTA) Repetitive transcranial magnetic stimulation for treatment-resistant major depression
2017     The Regional Health Technology Assessment Centre (HTA-centrum) Repetitive transcranial magnetic stimulation in the management of chronic neuropathic pain
2008     Haute Autorite de sante (HAS) Replacement aortic valves with transfemoral or transapical delivery systems
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Replacement enzyme therapy in Fabry's disease
2012     NIHR Horizon Scanning Centre (NIHR HSC) RePneu™ lung volume reduction coils for emphysema
2009     Health Information and Quality Authority (HIQA) Report of the evaluation of the use of resources in the national population-based cancer screening programmes and associated services
2008     Institute for Clinical Evaluative Sciences (ICES) Report on coronary artery bypass surgery in Ontario, fiscal years 2005/06 and 2006/07
1997     Andalusian Health Technology Assessment Area (AETSA) Report on New-Ger (N-duopropenide), a new disinfectant -non-systematic review
2003     Andalusian Health Technology Assessment Area (AETSA) Report on New-Ger (N-duopropenide), a new disinfectant. 2002 update - non-systematic review
2010     Agency for Healthcare Research and Quality (AHRQ) Report on the evidence regarding off-label indications for targeted therapies used in cancer treatment
2002     Andalusian Health Technology Assessment Area (AETSA) Report on the hearing-aid device AUDIGITAL ALFA 128
2010     HAYES, Inc. Repose Tongue and Hyoid Suspension (THS) system (Medtronic Xomed Inc.) for obstructive sleep apnea
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of arthroscopic shavers
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of arthroscopic wands
2008     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of cardiac positioning devices
2008     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of external fixation devices
2008     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of femoral vascular closure devices
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of laparoscopic trocars
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2008     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of single-use medical devices
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single-use medical devices: clinical, economic, and health services impact
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single-use medical devices: clinical, economic, and health services impact
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single-use medical devices: national survey of Canadian acute-care hospitals
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2008     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of tourniquet cuffs
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of ultrasonic scalpels
1996     Health Council of the Netherlands Gezondheidsraad (GR) Requirements for expertise in radiation applications in medicine
2008     Health Intervention and Technology Assessment Program (HITAP) Research for development of an optimal policy strategy for prevention and control of Cervical Cancer in Thailand
2001     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Research on human beings. Report about the hearing on September 24, 2001 in Berne
2002     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Research on human embryonic stem cells. Report about citizen opinions